Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mFOLFOX6”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Large-scale testing (Phase 3)Study completedNCT03231722
What this trial is testing

First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 435
Large-scale testing (Phase 3)Study completedNCT02776683
What this trial is testing

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Boehringer Ingelheim 123
Testing effectiveness (Phase 2)UnknownNCT02280070
What this trial is testing

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Who this might be right for
Rectal Cancer
Clinical Research Support Center Kyush 110
Testing effectiveness (Phase 2)Looking for participantsNCT06002789
What this trial is testing

Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC

Who this might be right for
Multiple CancerColorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 17
Early research (Phase 1)Study completedNCT04761614
What this trial is testing

Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8+2 more
Ning Jin 13
Testing effectiveness (Phase 2)Study completedNCT00193219
What this trial is testing

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer
SCRI Development Innovations, LLC 36
Large-scale testing (Phase 3)Study completedNCT03365765
What this trial is testing

MFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer

Who this might be right for
Apatinib
Huashan Hospital 63
Large-scale testing (Phase 3)Active Not RecruitingNCT02997228
What this trial is testing

Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

Who this might be right for
Metastatic Colorectal AdenocarcinomaStage IV Colorectal Cancer AJCC v7
National Cancer Institute (NCI) 120
Not applicableUnknownNCT06335147
What this trial is testing

PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer

Who this might be right for
Metastatic Colon Cancer
Henan Cancer Hospital 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03921684
What this trial is testing

Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients

Who this might be right for
Rectal Cancer
Baruch Brenner 29
Testing effectiveness (Phase 2)UnknownNCT01832948
What this trial is testing

Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Zhejiang Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00819780
What this trial is testing

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+1 more
Amgen 285
Large-scale testing (Phase 3)UnknownNCT01566942
What this trial is testing

FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 200
Testing effectiveness (Phase 2)UnknownNCT01322178
What this trial is testing

Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 90
Early research (Phase 1)Study completedNCT00934882
What this trial is testing

Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI

Who this might be right for
Colorectal Neoplasms
Bayer 45
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Testing effectiveness (Phase 2)Study completedNCT01327612
What this trial is testing

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Who this might be right for
Advanced Solid TumorsCarcinoidColorectal Cancer+6 more
Amgen 12
Large-scale testing (Phase 3)Ended earlyNCT03654729
What this trial is testing

Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)

Who this might be right for
Colorectal CancerChemotherapy-induced Peripheral Neuropathy
Egetis Therapeutics 291
Large-scale testing (Phase 3)Temporarily pausedNCT00316745
What this trial is testing

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group 200
Testing effectiveness (Phase 2)WithdrawnNCT02344810
What this trial is testing

C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
Eastern Cooperative Oncology Group
Load More Results